<VariationArchive VariationID="14548" VariationName="NM_000228.3(LAMB3):c.1587_1588del (p.Gly530fs)" VariationType="Deletion" Accession="VCV000014548" Version="6" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-06-10" DateCreated="2015-04-20" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="29587" VariationID="14548">
      <GeneList>
        <Gene Symbol="LAMB3" FullName="laminin subunit beta 3" GeneID="3914" HGNC_ID="HGNC:6490" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q32.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="209614870" stop="209652425" display_start="209614870" display_stop="209652425" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="209788214" stop="209825819" display_start="209788214" display_stop="209825819" Strand="-" />
          </Location>
          <OMIM>150310</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000228.3(LAMB3):c.1587_1588del (p.Gly530fs)</Name>
      <CanonicalSPDI>NC_000001.11:209626875:CT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q32.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="209626876" stop="209626877" display_start="209626876" display_stop="209626877" variantLength="2" positionVCF="209626875" referenceAlleleVCF="CCT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="209800221" stop="209800222" display_start="209800221" display_stop="209800222" variantLength="2" positionVCF="209800220" referenceAlleleVCF="CCT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>G530fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.209800221_209800222del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.209800221_209800222del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.209626876_209626877del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.209626876_209626877del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007116.1" sequenceAccession="NG_007116" sequenceVersion="1" change="g.30599_30600del">
            <Expression>NG_007116.1:g.30599_30600del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000228.3" sequenceAccession="NM_000228" sequenceVersion="3" change="c.1587_1588del" MANESelect="true">
            <Expression>NM_000228.3:c.1587_1588del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000219.2" sequenceAccession="NP_000219" sequenceVersion="2" change="p.Gly530fs">
            <Expression>NP_000219.2:p.Gly530fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001017402.2" sequenceAccession="NM_001017402" sequenceVersion="2" change="c.1587_1588del">
            <Expression>NM_001017402.2:c.1587_1588del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001017402.1" sequenceAccession="NP_001017402" sequenceVersion="1" change="p.Gly530fs">
            <Expression>NP_001017402.1:p.Gly530fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127641.1" sequenceAccession="NM_001127641" sequenceVersion="1" change="c.1587_1588del">
            <Expression>NM_001127641.1:c.1587_1588del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121113.1" sequenceAccession="NP_001121113" sequenceVersion="1" change="p.Gly530fs">
            <Expression>NP_001121113.1:p.Gly530fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA257283" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="150310.0011" DB="OMIM" />
        <XRef Type="rs" ID="769151482" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 11689492 Fig. 2A to determine the location of this allele on the current reference sequence.</Comment>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000228.3(LAMB3):c.1587_1588del (p.Gly530fs) AND Junctional epidermolysis bullosa gravis of Herlitz" Accession="RCV000015649" Version="27">
        <ClassifiedConditionList TraitSetID="2421">
          <ClassifiedCondition DB="MedGen" ID="C0079683">Junctional epidermolysis bullosa gravis of Herlitz</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-01-26" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000228.3(LAMB3):c.1587_1588del (p.Gly530fs) AND Junctional epidermolysis bullosa" Accession="RCV002509160" Version="1">
        <ClassifiedConditionList TraitSetID="13197">
          <ClassifiedCondition DB="MedGen" ID="C0079301">Junctional epidermolysis bullosa</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000228.3(LAMB3):c.1587_1588del (p.Gly530fs) AND not provided" Accession="RCV002513066" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-14" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2015-04-20" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11023379</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11689492</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15373767</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16473856</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24947307</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2421" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5022" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE</ElementValue>
                <XRef Type="MIM" ID="226700" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0007" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, HERLITZ TYPE</ElementValue>
                <XRef Type="MIM" ID="226700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Junctional epidermolysis bullosa gravis of Herlitz</ElementValue>
                <XRef ID="Epidermolysis+Bullosa+Letalis/2580" DB="Genetic Alliance" />
                <XRef ID="400140006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Herlitz-type junctional epidermolysis bullosa</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">JEB-HERLITZ TYPE</ElementValue>
                <XRef Type="MIM" ID="226700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis Bullosa Letalis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa, junctional, Herlitz-Pearson type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Herlitz-Pearson type epidermolysis bullosa</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">LAMB3-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMC2-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMA3-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2153" />
                <XRef ID="2153" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Junctional epidermolysis bullosa (JEB) is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers and toes, and internally around the upper airway. Blisters generally heal with no significant scarring. Broad classification of JEB includes JEB generalized severe and JEB generalized intermediate. In JEB generalized severe, blisters are present at birth or become apparent in the neonatal period. Congenital malformations of the urinary tract and bladder may also occur. In JEB generalized intermediate, the phenotype may be mild with blistering localized to hands, feet, knees, and elbows with or without renal or ureteral involvement. Some individuals never blister after the newborn period. Additional features shared by JEB and the other major forms of epidermolysis bullosa (EB) include congenital localized absence of skin (aplasia cutis congenita), milia, nail dystrophy, scarring alopecia, hypotrichosis, pseudosyndactyly, and other contractures.</Attribute>
                <XRef ID="NBK1125" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301304</ID>
                <ID Source="BookShelf">NBK1125</ID>
              </Citation>
              <XRef ID="79404" DB="Orphanet" />
              <XRef ID="C0079683" DB="MedGen" />
              <XRef ID="MONDO:0009182" DB="MONDO" />
              <XRef Type="MIM" ID="226700" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13197" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9513" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Junctional epidermolysis bullosa</ElementValue>
                <XRef ID="MONDO:0017612" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Junctional epidermolysis bullosa (JEB) is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers and toes, and internally around the upper airway. Blisters generally heal with no significant scarring. Broad classification of JEB includes JEB generalized severe and JEB generalized intermediate. In JEB generalized severe, blisters are present at birth or become apparent in the neonatal period. Congenital malformations of the urinary tract and bladder may also occur. In JEB generalized intermediate, the phenotype may be mild with blistering localized to hands, feet, knees, and elbows with or without renal or ureteral involvement. Some individuals never blister after the newborn period. Additional features shared by JEB and the other major forms of epidermolysis bullosa (EB) include congenital localized absence of skin (aplasia cutis congenita), milia, nail dystrophy, scarring alopecia, hypotrichosis, pseudosyndactyly, and other contractures.</Attribute>
                <XRef ID="NBK1125" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2152" />
                <XRef ID="2152" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301304</ID>
                <ID Source="BookShelf">NBK1125</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="305" DB="Orphanet" />
              <XRef ID="C0079301" DB="MedGen" />
              <XRef ID="MONDO:0017612" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS226650" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1539621" SubmissionDate="2018-07-10" DateLastUpdated="2015-10-11" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="23659|OMIM:226700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000789317" DateUpdated="2015-10-11" DateCreated="2015-10-11" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-01-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24947307</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11689492</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sbjulxjt/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMB3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" alternateAllele="C" referenceAllele="CCT" start="209800220" stop="209800222" variantLength="3" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000228.2:c.1587_1588delAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="226700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="35914" SubmissionDate="2015-04-17" DateLastUpdated="2024-06-09" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="150310.0011_EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE" title="LAMB3, 2-BP DEL, NT1587_EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE" />
        <ClinVarAccession Accession="SCV000035914" DateUpdated="2024-06-09" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with severe junctional epidermolysis bullosa (JEB1B; 226700) at birth, Gache et al. (2001) found a heterozygous A-to-G deletion at position 1587 of exon 13. This 1587delAG deletion led to a shift of the reading frame and resulted in a downstream premature termination codon in exon 14. This mutation was in compound heterozygous state with the R635X (150310.0001) mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">11689492</ID>
              </Citation>
              <XRef DB="OMIM" ID="226700" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMB3" />
          </GeneList>
          <Name>LAMB3, 2-BP DEL, NT1587</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, NT1587</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="150310.0011" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5505065" SubmissionDate="2023-01-11" DateLastUpdated="2023-01-15" DateCreated="2023-01-15">
        <ClinVarSubmissionID localKey="NM_000228.2:c.1587_1588delAG|MedGen:C0079301" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002819943" DateUpdated="2023-01-15" DateCreated="2023-01-15" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15373767</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11689492</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24947307</ID>
          </Citation>
          <Comment>Variant summary: LAMB3 c.1587_1588delAG (p.Gly530MetfsX5) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 4e-06 in 250330 control chromosomes. c.1587_1588delAG has been reported in the literature in individuals affected with Junctional Epidermolysis Bullosa in the homozygous and compound heterozygous state (eg. Gache_2001, Posteraro_2004, Takeichi_2015). These data indicate that the variant is likely to be associated with disease. RT-PCR studies have shown the variant restores the open-reading frame of a naturally occurring out-of-frame exon 14-skipped mRNA transcript which, thus, escapes nonsense-mediated decay (Hentze and Kulozik, 1999) and can accumulate in the cells as a single mRNA species (Posteraro_2004, Takeichi_2015). RT-PCR amplification of total RNA purified from skin biopsies of a patient with the variant showed that the mutated mRNAs underwent rapid decay shortly after birth, and that illegitimate splicing of the mRNA carrying c.1587_1588delAG generated a new internally shortened transcript with advancing age, which correlated with the patient's marked improvement of skin adhesion with advancing age (Gache_2001). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMB3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000228.2:c.1587_1588delAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0079301" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12529442</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6213485" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4823378|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003524029" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11689492</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11023379</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16473856</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 14548). This variant is also known as 1587delAG. This premature translational stop signal has been observed in individual(s) with junctional epidermolysis bullosa (PMID: 11689492). This variant is present in population databases (rs769151482, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Gly530Metfs*5) in the LAMB3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LAMB3 are known to be pathogenic (PMID: 11023379, 16473856).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMB3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.209800221_209800222del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1539621" TraitType="Disease" MappingType="XRef" MappingValue="226700" MappingRef="OMIM">
        <MedGen CUI="C0079683" Name="Junctional epidermolysis bullosa gravis of Herlitz" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6213485" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="35914" TraitType="Disease" MappingType="Name" MappingValue="EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE" MappingRef="Preferred">
        <MedGen CUI="C0079683" Name="Junctional epidermolysis bullosa gravis of Herlitz" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5505065" TraitType="Disease" MappingType="XRef" MappingValue="C0079301" MappingRef="MedGen">
        <MedGen CUI="C0079301" Name="Junctional epidermolysis bullosa" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

